Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Escherichia coli | penicillin-binding protein | Starlite/ChEMBL | No references |
Homo sapiens | SMAD family member 2 | Starlite/ChEMBL | No references |
Homo sapiens | GNAS complex locus | Starlite/ChEMBL | No references |
Equus caballus | Ferritin light chain | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Schistosoma mansoni | apoferritin-2 | Ferritin light chain | 175 aa | 146 aa | 28.8 % |
Schistosoma mansoni | ferritin | Ferritin light chain | 175 aa | 171 aa | 44.4 % |
Schistosoma mansoni | GTP-binding protein alpha subunit gna | GNAS complex locus | 394 aa | 450 aa | 28.7 % |
Schistosoma mansoni | ferritin | Ferritin light chain | 175 aa | 171 aa | 43.9 % |
Echinococcus multilocularis | expressed protein | Ferritin light chain | 175 aa | 146 aa | 30.1 % |
Echinococcus granulosus | expressed protein | Ferritin light chain | 175 aa | 146 aa | 28.8 % |
Schistosoma mansoni | apoferritin-2 | Ferritin light chain | 175 aa | 142 aa | 29.6 % |
Brugia malayi | MH2 domain containing protein | SMAD family member 2 | 467 aa | 405 aa | 31.6 % |
Schistosoma japonicum | Ferritin, putative | Ferritin light chain | 175 aa | 144 aa | 24.3 % |
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.0983 | 0.0708 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.011 | 0.2812 | 0.2812 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0055 | 0.0983 | 0.0708 |
Schistosoma mansoni | tar DNA-binding protein | 0.0324 | 1 | 1 |
Loa Loa (eye worm) | glutaminase 2 | 0.0266 | 0.8048 | 0.8048 |
Plasmodium vivax | hypothetical protein, conserved | 0.0043 | 0.0589 | 1 |
Echinococcus granulosus | tar DNA binding protein | 0.0324 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.0589 | 0.0589 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0324 | 1 | 1 |
Loa Loa (eye worm) | glutaminase | 0.0266 | 0.8048 | 0.8048 |
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.0589 | 0.0589 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0035 | 0.0296 | 0.0296 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0026 | 0 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0324 | 1 | 1 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0035 | 0.0296 | 0.0296 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0055 | 0.0983 | 0.0708 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0055 | 0.0983 | 0.0708 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.0043 | 0.0589 | 0.0302 |
Mycobacterium leprae | Probable lipase LipE | 0.0043 | 0.0589 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.0589 | 0.0589 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0035 | 0.0296 | 0.0296 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0043 | 0.0589 | 1 |
Mycobacterium tuberculosis | Possible penicillin-binding protein | 0.0278 | 0.8443 | 1 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.011 | 0.2812 | 0.2812 |
Brugia malayi | beta-lactamase family protein | 0.0043 | 0.0589 | 0.0589 |
Brugia malayi | beta-lactamase | 0.0043 | 0.0589 | 0.0589 |
Loa Loa (eye worm) | beta-LACTamase domain containing family member | 0.0043 | 0.0589 | 0.0589 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0324 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.0589 | 0.0589 |
Onchocerca volvulus | 0.0043 | 0.0589 | 0.5 | |
Loa Loa (eye worm) | hypothetical protein | 0.0035 | 0.0296 | 0.0296 |
Schistosoma mansoni | hypothetical protein | 0.0075 | 0.1647 | 0.1393 |
Trichomonas vaginalis | glutaminase, putative | 0.0266 | 0.8048 | 1 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0055 | 0.0983 | 0.0983 |
Leishmania major | hypothetical protein, conserved | 0.0043 | 0.0589 | 1 |
Loa Loa (eye worm) | beta-lactamase | 0.0043 | 0.0589 | 0.0589 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0055 | 0.0983 | 0.0983 |
Brugia malayi | beta-lactamase family protein | 0.0043 | 0.0589 | 0.0589 |
Schistosoma mansoni | tar DNA-binding protein | 0.0324 | 1 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0324 | 1 | 1 |
Brugia malayi | TAR-binding protein | 0.0324 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.0589 | 0.0589 |
Onchocerca volvulus | 0.0043 | 0.0589 | 0.5 | |
Toxoplasma gondii | ABC1 family protein | 0.0043 | 0.0589 | 1 |
Brugia malayi | MH2 domain containing protein | 0.0144 | 0.3964 | 0.3964 |
Echinococcus multilocularis | beta LACTamase domain containing family member | 0.0043 | 0.0589 | 0.0302 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0055 | 0.0983 | 0.0708 |
Loa Loa (eye worm) | RNA binding protein | 0.0324 | 1 | 1 |
Mycobacterium ulcerans | glutaminase | 0.0266 | 0.8048 | 1 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0043 | 0.0589 | 1 |
Onchocerca volvulus | 0.0043 | 0.0589 | 0.5 | |
Echinococcus multilocularis | tar DNA binding protein | 0.0324 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0075 | 0.1647 | 0.1647 |
Loa Loa (eye worm) | hypothetical protein | 0.011 | 0.2812 | 0.2812 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.0983 | 0.0708 |
Schistosoma mansoni | glutaminase | 0.0266 | 0.8048 | 0.7988 |
Brugia malayi | glutaminase DH11.1 | 0.0266 | 0.8048 | 0.8048 |
Mycobacterium leprae | conserved hypothetical protein | 0.0043 | 0.0589 | 0.5 |
Brugia malayi | Hypothetical 52.5 kDa protein ZK945.1 in chromosome II, putative | 0.0043 | 0.0589 | 0.0589 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0144 | 0.3964 | 0.3964 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.011 | 0.2812 | 0.2812 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.0043 | 0.0589 | 0.0302 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0075 | 0.1647 | 0.1647 |
Echinococcus granulosus | beta LACTamase domain containing family member | 0.0043 | 0.0589 | 0.0302 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0026 | 0 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0324 | 1 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.0983 | 0.0708 |
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.0589 | 0.0589 |
Loa Loa (eye worm) | TAR-binding protein | 0.0324 | 1 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0043 | 0.0589 | 1 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0144 | 0.3964 | 0.3964 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 5.6234 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | 9.285 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 12.5893 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (binding) | = 15.8489 um | PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)] | ChEMBL. | No reference |
Potency (functional) | = 17.7828 um | PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))] | ChEMBL. | No reference |
Potency (functional) | 17.7828 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PUBCHEM_BIOASSAY: Confirmation Assay for Identification of Novel General Anesthetics. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2323, AID2385, AID485281] | ChEMBL. | No reference |
Potency (functional) | 100 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.